TY - JOUR
T1 - Utility of closed suction pelvic drains at time of large bowel resection for ovarian cancer
AU - Kalogera, Eleftheria
AU - Dowdy, Sean C.
AU - Mariani, Andrea
AU - Aletti, Giovanni
AU - Bakkum-Gamez, Jamie N.
AU - Cliby, William A.
N1 - Funding Information:
This work was partially supported by the National Institutes of Health Grant ( R01CA148747 to WAC) and the Office of Women's Health Research Building Interdisciplinary Careers in Women's Health (BIRCWH award K12 HD065987 to JNB).
PY - 2012/9
Y1 - 2012/9
N2 - Objective: To test the hypothesis that the use of closed suction pelvic drains placed at time of large bowel resection (LBR) for ovarian cancer (OC) decreases morbidity following anastomotic leak (AL). Methods: Consecutive cases of LBR for OC between 01/01/1994 and 06/20/2011 were retrospectively identified. Drains were routinely used until bowel movement. AL was defined as: 1) feculent fluid from drains/wound/vagina, 2) radiographic evidence of AL, or 3) AL found at reoperation. Descriptive statistics, Wilcoxon rank-sum, Pearson's chi-square and Fisher's exact test were used. Results: 43 cases met inclusion criteria. AL was characterized by method of diagnosis as follows: change in drain output only (DO, n = 8); change in drain output associated with ambiguous clinical signs/symptoms (D-SSX, n = 11); or clinical signs/symptoms only (SSX, n = 24). The sensitivity of drains in diagnosing AL was 50%. Time to diagnosis was earlier in DO/D-SSX (median 7 vs. 11 days, P = 0.003), however, no significant differences were observed in rates of reoperation, length of stay, time to chemotherapy (TTC), and 30- and 90-day mortality between DO/D-SSX and SSX. Comparing cases where no drains were placed (n = 5) vs. those with drain (n = 38), we observed no differences in outcomes. TTC though statistically significant (47 vs. 59 days, P = 0.023) was not clinically significant. Conclusions: Though a change in drain output correlated with earlier diagnosis, this did not appear to impact overall outcomes. We did not find strong evidence supporting routine prolonged drainage after LBR for OC. Additionally, absence of change in drain output does not rule out presence of AL.
AB - Objective: To test the hypothesis that the use of closed suction pelvic drains placed at time of large bowel resection (LBR) for ovarian cancer (OC) decreases morbidity following anastomotic leak (AL). Methods: Consecutive cases of LBR for OC between 01/01/1994 and 06/20/2011 were retrospectively identified. Drains were routinely used until bowel movement. AL was defined as: 1) feculent fluid from drains/wound/vagina, 2) radiographic evidence of AL, or 3) AL found at reoperation. Descriptive statistics, Wilcoxon rank-sum, Pearson's chi-square and Fisher's exact test were used. Results: 43 cases met inclusion criteria. AL was characterized by method of diagnosis as follows: change in drain output only (DO, n = 8); change in drain output associated with ambiguous clinical signs/symptoms (D-SSX, n = 11); or clinical signs/symptoms only (SSX, n = 24). The sensitivity of drains in diagnosing AL was 50%. Time to diagnosis was earlier in DO/D-SSX (median 7 vs. 11 days, P = 0.003), however, no significant differences were observed in rates of reoperation, length of stay, time to chemotherapy (TTC), and 30- and 90-day mortality between DO/D-SSX and SSX. Comparing cases where no drains were placed (n = 5) vs. those with drain (n = 38), we observed no differences in outcomes. TTC though statistically significant (47 vs. 59 days, P = 0.023) was not clinically significant. Conclusions: Though a change in drain output correlated with earlier diagnosis, this did not appear to impact overall outcomes. We did not find strong evidence supporting routine prolonged drainage after LBR for OC. Additionally, absence of change in drain output does not rule out presence of AL.
KW - Anastomotic leak
KW - Large bowel resection
KW - Ovarian cancer
KW - Pelvic drain
UR - http://www.scopus.com/inward/record.url?scp=84864413516&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864413516&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2012.05.021
DO - 10.1016/j.ygyno.2012.05.021
M3 - Article
C2 - 22617523
AN - SCOPUS:84864413516
SN - 0090-8258
VL - 126
SP - 391
EP - 396
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -